AI retinopathy screening cheaper than human grading

A new study suggests that deep learning systems (DLS) would eliminate two minutes of human labour required to grade diabetic retinopathy images, however a semi-automated model is most cost-effective, saving national health systems up to 20% on screening costs. Read more

Where are we with MIGS?

 

The 2014 arrival of MIGS to Australia introduced a whole new field of interventional glaucoma therapies. Queensland ophthalmologist Dr Frank Howes re-defines the term and explores current surgical interventions, explaining where each fits in the glaucoma treatment algorithm. Read more